Provided sample report
Retatrutide 10 mg
Vanguard Laboratory · V260119-7 001
Read this document note
Source title/sample heading has visibly missing letters and chromatogram shows white gaps; body compound and quantity are readable. Preserve original and require source review before presenting as verified authenticity. Endotoxin result recorded as written.
- Sample
- Retatrutide 10 mg
- Sample specification
- 10 mg
- Laboratory shown
- Vanguard Laboratory
- Submitting client shown
- Optimum Formula
- Report number
- V260119-7 001
- Sample lot / batch
- BG4MA
- Date reported
- 2026-02-06
| Test shown | Method shown | Reported result |
|---|---|---|
| Chromatographic Purity | HPLC-UV/VIS | >99.80% ± 0.18% |
| Quantity | HPLC-UV/VIS | 10.41 mg |
| Sterility | USP <71> | Pass - No Growth Detected |
| Endotoxins | LAL | Pass - 11.00 EU/mg* |
Results are transcribed from this sample report. The original document takes precedence; these results are not specifications or guarantees for other samples.
The submitting client is Optimum Formula. The connection between this sample lot and current NorthVerity inventory has not been established. Request the current lot document with your inquiry.
Other original files for this report number
This report has separate original result pages. Read them together.
Related catalog entries
The links below are references based on catalog naming. Confirm the chemical form, blend composition, specification and current inventory lot separately.
Original-file fingerprint
SHA-256: fd78b30e5e28e2d943158f54c9dfbfca32fda0eab9fd44093b5e2857f973805c